Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Valeo Pharma Inc (EM)
VPHIF
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs. The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas. It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and...
commercialization through all stages. The company offers access to product specialists and medical information for healthcare professionals and patients. Valeo Pharma serves healthcare professionals, including Canadian physicians, and focuses on hospital specialty sectors. The company was founded in 2003 and is based in Kirkland, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:VPHIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jan 29, 2024 5:59pm
Fourth Quarter and year-end 2023 Webcast and Conference Call
Valeo will host a conference call to discuss its fourth quarter and year-end 2023 results and highlights on Tuesday January 30, 2024, at 8.30 am (ET). The telephone numbers to access the
...more
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jan 29, 2024 5:57pm
VALEO PHARMA REPORTS RECORD ANNUAL REVENUES
Record revenues of $54 million for fiscal 2023, up 94% over 2022 Revenues of $13.1 million for Q4-23, up 4% over Q4-22 Record annual adjusted gross profit of $16.9
...more
(0)
•••
Bluechips19
X
Post by
Bluechips19
on Nov 22, 2023 11:52pm
VPH
Interesting opportunityi high revenue high expenses. See where this sits next spring could be a nice play here at these levels
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jul 04, 2023 6:04pm
UPDATE ON OPHTHALMOLOGY BUSINESS UNIT T.VPH
Novartis agrees to sell global rights to XIIDRA® and several other ophthalmology products to Baucsh + Lomb SIMBRINZA® not included in the divestiture MONTREAL, July 4, 2023
...more
(0)
•••
NonoRobotSG
X
Post by
NonoRobotSG
on Jun 15, 2023 11:19am
VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES
VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES - Valeo Pharma
(20)
•••
Royal10
X
Post by
Royal10
on Jun 06, 2023 3:55pm
VPH: To profit from forest fires!
VPH sells products with a focus on Respiratory/Allergy.
(20)
•••
Royal10
X
Post by
Royal10
on Mar 15, 2023 10:44am
VPH: ECHELON's target price: $1.00!
Valeo Pharma trades at 55 cents today. The co will report its Q1/23 results after the close today! I am very anxious to see these results! Some analysts expect a loss of $0.09 ! We never know ..
...more
(20)
•••
Royal10
X
Comment by
Royal10
on Nov 15, 2022 1:39pm
RE:VPH: Announces higher revenue guidance for Q4/2022.
Technically , VPH could potentially double in the next few weeks. Simple Moving Avg (30) ——Simple Moving Avg (90) ——
(20)
•••
Royal10
X
Post by
Royal10
on Nov 15, 2022 1:34pm
VPH: Announces higher revenue guidance for Q4/2022.
VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE Valeo Pharma Inc. has raised revenue guidance for its fourth quarter of 2022 to $12.5-million to $13-million, an increase of 14 per cent to
...more
(54)
•••
bmreed
X
Post by
bmreed
on Sep 26, 2022 1:06pm
Video Recap - $VPH CEO Steve Saviuk and Radius Research
Webinar Recap: Valeo Pharma (VPH) w CEO Steve Saviuk - Pitch, Deep Dive and Q&A - https://youtu.be/ESItGs4uVuk CEO Steve Saviuk discusses recent Q3 Financials and the new addition of
...more
(54)
•••
bmreed
X
Post by
bmreed
on Sep 16, 2022 1:01pm
Webinar w $VPH CEO Steve Saviuk - Tue Sep 20 @ 1:30PM ET
Webinar - Valeo Pharma $VPH w/ CEO Steve Saviuk Tue, September 20 at 1:30pm ET / 10:30am PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar/register
...more
(109)
•••
TrevorAbes
X
Post by
TrevorAbes
on Aug 02, 2022 5:40pm
Valeo Pharma (TSX:VPH) partners with Novartis
https://themarketherald.ca/valeo-pharma-tsxvph-partners-with-novartis-2022-08-02/
(48)
•••
vanbmtz
X
Post by
vanbmtz
on Jun 16, 2022 1:17pm
Commercializing Innovative Prescription Products in Canada
Watch Valeo's presentation shortly. They are up at 10:30am PT / 1:30pm ET. Here's the link to tune in
(1053)
•••
eric_a_su
X
Post by
eric_a_su
on Mar 30, 2022 9:30am
new video
(19)
•••
CanadianJrs
X
Post by
CanadianJrs
on Mar 25, 2022 6:18pm
TSX update 4:59
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Eshbal quickly expanding commercial and consumer footprint for gluten-free and health food brands
Podcasts